Sabra Health Care REIT, Inc. (SBRA) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reflects a positive sentiment, with strong financial metrics such as increased FFO and AFFO, a steady dividend, and a busy deal pipeline. Though management provided moderate guidance, they expressed optimism about occupancy trends and market demand. The Q&A highlighted positive occupancy trends, a robust acquisition pipeline, and no major risks, reinforcing a positive outlook. Given the market cap, a 2% to 8% stock price increase is expected.
Key Financial Performance
Medicaid rate increases Average increase of 3.5%, with top 5 skilled nursing tenants averaging just above 5%. This reflects a good year for Medicaid rate increases.
Medicare market rate Finalized upward from 2.8% to 3.2%, which is unusual but positive.
Triple net rent coverage Increased significantly across all asset classes, reaching new highs in skilled and senior housing triple-net.
Occupancy in skilled portfolio Continues to increase, with contract labor and employment levels now at pre-pandemic levels.
Cash NOI and cash NOI margin Up 5.3% and 70 basis points, respectively, on a sequential basis for the total managed portfolio.
Same-store managed senior housing portfolio revenue Grew 5.6% year-over-year.
Same-store portfolio occupancy Increased to 86% from 84.6% in Q2 2024. Domestic portfolio occupancy rose to 83.5%, gaining 190 basis points year-over-year.
RevPOR (Revenue per Occupied Room) Increased 3.9% year-over-year in the U.S. portfolio and 6.8% in the Canadian portfolio, where occupancy has been above 90% for over 5 quarters.
Cash NOI for same-store portfolio Grew 17.1% year-over-year. U.S. communities saw a 17.6% increase, while Canadian communities experienced a 15.9% increase.
Normalized FFO per share $0.37 for Q2 2025, a 6% improvement over the same period in 2024.
Normalized AFFO per share $0.38 for Q2 2025, a 6% improvement over the same period in 2024.
Cash rental income from triple-net portfolio Increased by $2.3 million from Q1 2025, driven by a $1.4 million increase in percentage rents and contractual annual rent increases.
Cash NOI from managed senior housing portfolio Increased to $25.3 million in Q2 2025 from $24.1 million in Q1 2025.
Net debt to adjusted EBITDA ratio 5x as of June 30, 2025, a decrease of 0.19x from March 31, 2025, and 0.45x from June 30, 2024.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Holiday Transition: Transitioned from Holiday to new operators Discovery, In Spirits, and Sunshine to improve portfolio performance.
Senior Housing Investments: Closed $122 million in senior housing investments and awarded $220 million more, expected to close by year-end.
Medicaid Rate Increases: Average Medicaid rate increases of 3.5%, with top 5 skilled nursing tenants averaging above 5%.
Medicare Market Update: Medicare rate finalized upward from 2.8% to 3.2%.
Triple Net Rent Coverage: Significant increase in all asset classes, reaching new highs in skilled and senior housing triple-net.
Occupancy and Skill Mix: Improved occupancy and skill mix in the skilled portfolio.
Labor Costs: Contract labor and employment levels returned to pre-pandemic levels.
Investment Pipeline: Targeting $500 million in investments for 2025, with $350 million in deals closed or in process.
SHOP Portfolio Expansion: Aiming to grow SHOP portfolio from 20% to 30% by 2026, requiring $1 billion in investments.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Holiday Transition: The company has not seen the same uplift in performance from the Holiday portfolio post-pandemic compared to the rest of its SHOP portfolio, leading to a decision to transition away from Holiday.
Medicaid and Medicare Reimbursement: While Medicaid rate increases are averaging 3.5% and Medicare rates have been finalized upward, there is inherent uncertainty in future reimbursement rates, which could impact financial performance.
High Cost of Capital and Materials: The high cost of capital, building materials, and labor is constraining the development of new inventory, potentially limiting growth opportunities.
Tenant Lease Collectibility: The company updated its estimate of collectibility for certain leases, indicating potential risks in tenant payment reliability.
Debt and Interest Rate Exposure: The company has refinanced $500 million in debt with a floating interest rate term loan, which, despite being hedged, introduces some exposure to interest rate fluctuations.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Medicaid rate increases: Expected to average 3.5%, with top 5 skilled nursing tenants averaging just above 5%.
Medicare market adjustment: Finalized upward from 2.8% to 3.2%.
Investment pipeline: Targeting $500 million in investments for 2025, with $200 million in awarded deals either closed or in the process of closing, and $300 million actively being worked on. Goal to increase SHOP (Senior Housing Operating Portfolio) from 20% to 30% by 2026, requiring $1 billion in investments.
Senior housing investments: Closed $122 million in senior housing investments so far in 2025, with $220 million more expected to close by year-end. Deal flow remains strong.
Same-store managed senior housing portfolio: Cash NOI growth expected to be in the low to mid-teens for 2025.
Earnings guidance for 2025: Net income expected to be $0.77 to $0.79 per share. Normalized FFO expected to be $1.45 to $1.47 per share. Normalized AFFO expected to be $1.49 to $1.51 per share, representing a 5% and 4% increase, respectively, over 2024.
Debt management: Entered into a new 5-year $500 million term loan to refinance existing debt, reducing the effective interest rate to 4.64% and extending the weighted average maturity to nearly 5 years.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Cash Dividend: Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on August 29, 2025, to common stockholders of record as of the close of business on August 15, 2025. The dividend represents a payout of 79% of the second quarter normalized AFFO per share.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Rick, in the opening remarks, you mentioned a $350 million investment guide. Are you still confident in reaching $500 million for the year?
A:It will be somewhere in the $400 million to $500 million range, depending on timing. Some deals may close on January 1 for tax reasons, but it will be close.
Q:Do you think the rest of the investment number will be comprised of skilled nursing deals? What is keeping those deals from entering the pipeline?
A:Pricing is not an issue; it's about finding quality assets in the right markets. The majority will likely still be SHOP, but there is a focus on skilled nursing. The company is not interested in building a loan book or complex JV structures.
Q:Why not take up the guidance for same-store SHOP NOI, given it is running at the high end or above expectations?
A:The company hopes for upside but is taking a moderate approach to guidance to ensure they can beat it.
Q:Can you provide more color on same-store SHOP occupancy, given there wasn’t much sequential movement?
A:The transition of the Holiday portfolio on April 1 impacted the numbers. Excluding the transition noise, the numbers would have looked better.
Q:What is driving the skilled opportunities opening up? Is it related to the OBBBA or health system concerns?
A:There hasn’t been a significant change in the volume of skilled nursing coming to market. The recovery in fundamental operations has allowed for more robust pricing, but the reconciliation bill is not a concern.
Q:How do you expect component drivers for the SHOP portfolio to trend in the back half of the year?
A:The outlook is positive with no new inventory coming into the system. Demand is increasing due to aging demographics, and the focus is on assisted living and memory care in secondary markets.
Q:How are you getting comfortable with diversifying the tenant base for the Holiday transition portfolio?
A:Having less concentration in one operator is helpful. The company identifies operators that fit and asks them to submit proposals.
Q:How long have you been evaluating transitioning the Holiday assets, and when was the final decision made?
A:The process started last year after a leadership change at Holiday. By the end of the year, potential operators were identified, and the transition date was targeted.
Q:For the five assets excluded from the same-store pool, how impactful has the transition been? Are you planning to invest additional capital?
A:The excluded assets were underperforming, and capital has been invested in the entire portfolio over the last few years. Improvement is expected.
Q:How has occupancy trended for the Holiday assets through the quarter, and what is the momentum into July?
A:Tours and move-ins have picked up, while move-outs have declined. The transition noise is in the rearview mirror, and improvement in occupancy is expected.
Q:What is the timing and sustainability of the external growth pipeline into 2026?
A:The $350 million pipeline is spread out over the next quarters. The volume of deals is consistent, and the company is actively bidding on assets.
Q:What would the growth have been without the transition assets in the same-store pool?
A:The growth would have been better without the transition assets, but specific numbers were not disclosed.
Q:Is the acquisition pipeline focused on Canada?
A:The company continues to look at Canada but finds the pricing too rich due to lower debt rates and cap rates.
Q:Can you articulate the NOI upside from the Holiday transition?
A:The company expects improvement but cannot specify the amount or timeframe due to uncertainty.
Q:What is the mix of assets in the $220 million pipeline?
A:The assets are institutional quality, newer builds, and include senior housing in strong markets. Some deals are with trusted operators, while others are with new operators.
Q:What is the update on Community Care rent coverage, and are there any concerns?
A:Rent coverage declined slightly but remains strong at 1.77x. The operator is divesting a few facilities in tough markets, and no major concerns exist.
Q:Is there a risk of sequestration impacting Medicare in the next few years?
A:There is no immediate concern. The industry is in a strong position with declining supply, increasing occupancy, and healthy financials.
Q:What wage increases are operators passing along to employees, and are there differences between SNF and senior housing?
A:Wage increases are around 4% across both SNF and senior housing. This level has been consistent for three years.
Q:Are there any states or markets with particularly tight labor conditions?
A:Labor conditions have improved across the board, with no specific markets experiencing undue challenges.
Q:What is the selection criteria for new operators?
A:The company evaluates operators based on their operations, market choices, and quality outcomes. They also look for operators interested in growth.
Q:How has the buyer pool for SHOP assets changed?
A:The buyer pool remains consistent, with REITs and private capital being the primary players. Some private equity funds have stepped away, while others are entering cautiously.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the NOI upside from the Holiday transition, stating that it requires a crystal ball to predict. Additionally, they did not disclose the exact growth impact of excluding transition assets from the same-store pool.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AFFO NOI
AG Research
Alec Gregory
Atria perspective
Austin Todd
Baird Co
Bank AG
Banking Markets
Bergey Citigroup
BofA Securities
CEO Talya
CFO Secretary
Cash income
Chair opportunity
Executive VP
Health Care
Holiday
Inc Research
LLC Research
Lukas
Research Division
basis investment
demand
housing community
housing investment
increase percentage
investment end
momentum
percentage rent
relationship
remainder rent
store portfolio
venture asset
SBRA Transcript
Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Positive4-30
The earnings call presents a positive outlook with key financial metrics showing year-over-year growth: revenue up 5%, net income up 10%, and FFO up 7%. The guidance for 2026 indicates continued growth, and the strategic initiatives suggest proactive management. Despite risks mentioned in forward-looking statements, the overall sentiment is positive, supported by strong financial performance and strategic growth plans. With a market cap of $3.5 billion, the stock is likely to react positively, leading to a 2% to 8% increase over the next two weeks.
Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript
Positive2-13
The earnings call reveals strong financial health, strategic growth in the SHOP portfolio, and favorable market conditions for senior housing. Despite minimal skilled nursing investments, the company is focusing on high-growth areas with robust occupancy potential. Shareholder returns are stable with no debt concerns, and the market strategy is well-received. The Q&A did not reveal significant risks, and management's optimistic guidance supports a positive outlook. Given the market cap of $3.5 billion, the stock is likely to experience a positive movement of 2% to 8% over the next two weeks.
Sabra Health Care REIT, Inc. (SBRA) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call highlights strong financial metrics, strategic investments, and optimistic guidance, particularly in the senior housing sector. Despite the maintenance of guidance, the focus on SHOP investments and refinancing of debt are positive indicators. The Q&A reveals management's confidence in future growth, with strategic steps to stabilize and improve occupancy. The market cap suggests moderate volatility, leading to a positive stock price prediction in the range of 2% to 8%.
Sabra Health Care REIT, Inc. (SBRA) Q2 2025 Earnings Call Transcript
Positive8-5
The earnings call reflects a positive sentiment, with strong financial metrics such as increased FFO and AFFO, a steady dividend, and a busy deal pipeline. Though management provided moderate guidance, they expressed optimism about occupancy trends and market demand. The Q&A highlighted positive occupancy trends, a robust acquisition pipeline, and no major risks, reinforcing a positive outlook. Given the market cap, a 2% to 8% stock price increase is expected.
SBRA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
